Heart device aims to cut stroke risk without blood thinners
NCT ID NCT03088098
Summary
This study tested if a small device that plugs a part of the heart is safer and more effective than standard blood-thinning medications for preventing strokes. It involved 81 high-risk patients who had both a narrowed aortic valve (treated with a minimally invasive valve replacement) and an irregular heartbeat called atrial fibrillation. Patients were randomly assigned to receive either the implantable device or standard medical therapy and were followed for up to 5 years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.